Interleukin-18: Biological properties and clinical implications

European Cytokine Network

Volumn 11, Issue 1, 2000, Pages 15-25

  Lebel Binay, Sophie ^a,c   Berger, Anne ^b   Zinzindohoué, Franck ^b   Cugnene, Paul Henri ^b   Thiounn, Nicolas ^c   Fridman, W H ^a   Pagès, Franck ^a  

^a INSERM   (France)

^b Hopital Laennec   (France)

^c Hôpital Cochin ^*  (France)

Author keywords

Clinical implications; IL 18; Inflammation; TFN ; Th1 differentiation

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR;

CELL MEDIATED CYTOTOXICITY; IMMUNOCYTOTOXICITY; IMMUNOREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; NEOPLASMS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18;

EID: 0012122533     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. 1. Mosmann T R, Cherwinski H, Bond M W, Giedlin M A, Coffman C. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol 136:2348.
2. 2. Romagnani S. 1997. The Th1 /Th2 paradigm. (Review) Immunol. Today 18: 263.
3. 3. Mosmann T R, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. (Review) Immunol. Today 17: 138.
4. 4. Thompson C B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? (Review) Cell 81: 979.
5. 5. O'Garra A, Murphy K. 1994. Role of cytokincs in determining T-lymphocyte function. (Review) Curr. Opin. Immunol. 6: 458.
6. 6. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88.
7. 7. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Fujii M, Torigoe K, et al. 1996. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156: 4274.
8. 8. Fantuzzi G, Dinarello C A. 1999. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE, (caspase-1). (Review) J. Clin. Immunol. 19: 1.
9. 9. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S, et al. 1995. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63: 3966.
10. 10. Stoll S, Jonuleit H, Schmitt E, Muller G, Yamauchi H, Kurimoto M, Knop J, Enk A H. 1998. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur: J. Immunol. 28: 3231.
11. 11. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M. 1997. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158: 1541.
12. 12. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley S B, Menon S, Kastelein R, Bazan F, O'Garra A. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7: 571.
13. 13. Micallef M J, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, et al. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur: J. Immunol. 26: 1647.
14. 14. Puren A J, Razeghi P, Fantuzzi G, Dinarello C A. 1998. Interleukin-18 enhances lipopolysacchariec-induced interferon-gamma production in human whole blood cultures. J. Infect. Dis. 178: 1830.
15. 15. Olee T, Hashimoto S, Quach J, Lotz M. 1999. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol. 162: 1096.
16. 16. Rothe H, Jenkins N A, Copeland N G, Kolb H. 1997. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin, Invest. 99: 469.
17. 17. Nolan K F, Greaves D R, Waldmann H. 1998. The human interleukin-18 gene 1L-18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 51: 161.
18. 18. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming M A, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M. 1997. Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science 275: 206.
19. 19. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A. Quintal L, Sekut L, Talanian R, Paskind M, et al. 1997. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386: 619.
20. 20. Henkart P A. 1996. ICE. family proteases: mediators of all apoptotic cell death? (Review) Immunity 4: 195.
21. 21. Fantuzzi G, Puren A J, Harding M W, Livingston D J, Dinarello C A. 1998. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1 )-deficient mice. Blood 91: 2118.
22. 22. Kim Y M, Talanian R V, Li J, Billiar T R. 1998. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J. Immunol. 161: 4122.
23. 23. Fantuzzi G, Karasek J A, Reznikov L L, Puren A J, Cheronis J, Dinarello C A. 1998. A role for neutrophil proteinase-3 (PR-3) in the generation of active IL-18. Eur: Cyt. Netw. 9: 378 (Abs).
24. 24. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M, Okura T, Takakura-Yamamoto R, Torigoe K, Gu Y, Su M S S, et al. 1997. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin-18 in monocytic THP.1 cells. J. Biol. Chem. 272: 26595.
25. 25. Tone M, Thompson S A, Tone Y, Fairchild P J, Waldmann H. 1997. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J. Immunol. 159: 6156.
26. 26. Puren A J, Fantuzzi G, Dinarello C A. 1999. Gene expression, synthesis, and secretion of interleukin-18 and interleukin 1 beta are differentially regulated in human blood mononu-clear cells and mouse spleen cells. Proc. Natl. Acad. Sci. USA 96: 2256.
27. 27. Brossart P, Grunebach F, Stuhler G, Reichardt V L, Mohle R, Kanz L, Brugger W. 1998. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood 92: 4238.
28. 28. Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk A H. 1997. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159: 298.
29. 29. Conti B, Jahng J, Tinti C, Son J, Joh T. 1997. Induction of interferon-gamma inducing factor in the adrenal cortex. J. Biol. Chem. 272: 2035.
30. 30. Conti B, Park L C, Calingasan N Y, Kim Y, Kim H, Bae Y, Gibson G, Joh T H. 1999. Cultures of astrocytes and microglia express interleukin-18. Brain Res. Mol. Brain Res. 67: 46.
31. 31. Prinz M, Hanisch U K. 1999. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 72: 2215.
32. 32. Udagawa N, Horwood N J, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers T J, Martin T J, Gillespie M T. 1997. lnterleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J. Exp. Med. 185: 1005.
33. 33. Pages F, Berger A, Henglein B, Piqueras B, Danel C, Zinzindohoue F, Thiounn N, Cugnene P H, Fridman W H. 1999. Modulation of IL-18 expression in human colon carcinoma, consequences for tumor immune surveillance. Int. J. Cancer. 84: 326.
34. 34. Pages F, Lazar V, Berger A, Danel C, Lebel-Binay S, Zinzindohoue F, Desreumaux P, Cellier C, Thiounn N, Bellet D, et al. 1999. Immune consequences of interleukin-18 modulation in Crohn's disease. Submitted.
35. 35. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, et al. 1997. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272: 25737.
36. 36. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, Akira S. 1999. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162: 5041.
37. 37. Parnet P, Garka K E, Bonnert T P, Dower S K, Sims J E. 1996. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271: 3967.
38. 38. Dale M, Nicklin M J. 1999. lnterleukin-1 receptor cluster: gene organization of IL-1R2, IL-1R1, IL-1RL2 (IL-1Rrp2), IL-1RL1 (T1/ST2), and IL-18R1 (IL-1Rrp) on human chromosome 2q. Genomics 57: 177.
39. 39. O'Neill L A, Greene C. 1998. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinary in mammals, insects and plants. J. Leukoc. Biol. 63: 650.
40. 40. Born T L, Thomassen E, Bird T A, Sims J E. 1998. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273: 29445.
41. 41. Kunikata T, Torigoe K, Ushio S, Okura T, Ushio C, Yamauchi H, Ikeda M, Ikegami H, Kurimoto M. 1998. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell Immunol. 189: 135.
42. 42. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161: 3400.
43. 43. Xu D, Chan W L, Leung B P, Hunter D, Schulz K, Carter R W, McInnes I B, Robinson J H, Liew F Y. 1998. Selective expression and functions of interleukin-18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188: 1485.
44. +, and CD4 CD8 T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18. J. Immunol. 160: 3759.
45. 45. Dinarello C A. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antogonist. (Review) Int. Rev. Immunol. 16: 457.
46. 46. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9: 143.
47. 47. Kanakaraj P, Ngo K, Wu Y, Angulo A, Ghazal P, Harris C A, Siekierka J J, Peterson P A, Fung-Leung W P. 1999. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp Med. 189: 1129.
48. 48. Shapiro L, Puren A J, Barton H A, Novick D, Peskind R L, Shenkar R, Gu Y, Su M S, Dinarello C A. 1998. Interleukin-18 stimulates HIV type 1 in monocytic cells. Proc. Natl. Acad. Sci. USA 95: 12550.
49. 56 (lck) and MAPK in a murine Th1 clone. Biochem. Biophys. Res. Commun. 237: 126.
50. 50. Novick D, Kim S H, Fantuzzi G, Reznikov L L, Dinarello C A, Rubinstein M. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127.
51. 51. Aizawa Y, Akita M, Taniai M, Torigoe K, Mori T, Nishida Y, Ushio S, Nukada Y, Tanimoto T, Ikegami H, Ikeda M, Kurimoto M. 1999. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 445: 338.
52. 52. Xiang Y, Moss B. 1999. IL-18 binding and inhibition of interferon gamma induction by human poxvirus encoded proteins. Proc. Natl. Acad. Sci. USA 96: 11537.
53. 53. Trinchieri G. 1998. Proinflammatory and immunoregulatory functions of interleukin-12. (Review) Int. Rev. Immunol. 16: 365.
54. 54. Ahn H, Maruo S, Tomura M, Mu J, Hamaoka T, Nakanishi K, Clark S, Kurimoto M, Okamura H, Fujiwara H. 1997. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159: 2125.
55. + T lymphocytes. J. Immunol 160: 3642.
56. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29: 548.
57. 57. Magram J, Sfarra J, Connaughton S, Faherty D, Warrier R, Carvajal D, Wu C Y, Stewart C, Sarmiento U, Gately M K. 1996. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann. N.Y. Acad. Sci. 795: 60.
58. 58. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383.
59. + effector T cells is differentially regulated by IL-18 and IL-12. J. Immunol. 162: 3202.
60. 60. Hunter C, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan F, Kastelein R A. 1997. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Eur: J. Immunol. 27: 2787.
61. - cells. J. Immunol. 160: 4738.
62. 62. Yoshimoto T, Okamura H, Tagawa Y I, Iwakura Y, Nakanishi K. 1997. Interleukin-18 together with interleukin-12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA 94: 3948.
63. 63. Munder M, Mallo M, Eichmann K, Modolell M. 1998. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187: 2103.
64. 64. Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. 1996. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 173: 230.
65. 65. Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, Hiroishi K, Takeda K, Tagawa Y, Iwakura Y, et al. 1999. 1L-18 up-regulates perforin-mediated NK activity without increasing perform messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162: 1662.
66. 66. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K. 1996. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157: 3967.
67. 67. Hashimoto W, Osaki T, Okamura H, Robbins P D, Kurimoto M, Nagata S, Lotze M T, Tahara H. 1999. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand-and perforin-induced tumor apoptosis, respectively. J. Immunol. 163: 583.
68. 68. Dao T, Mehal W Z, Crispe I N. 1998. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161: 2217.
69. 69. Bossi G, Griffiths G M. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5: 90.
70. + human blood mononuclear cells. J. Clin. Invest. 101: 711.
71. 71. Fehniger T A, Shah M H, Turner M J, VanDeusen J B, Whitman S P, Cooper M A, Suzuki K, Wechser M, Goodsaid F, Caligiuri M A. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162: 4511.
72. 72. Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, Kurimoto M, Orita K, Akagi T, Tanaka N. 1998. Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J. Leukoc. Biol. 64: 519.
73. 73. Maestroeni P, Clare S, Khan S, Harrison J A, Hormaeche C E, Okamura H, Kurimoto M, Dougan G. 1999. Interleukin-18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67: 478.
74. 74. Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurimoto M, Heesemann J, Autenrieth I B. 1998. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160: 299.
75. 75. Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. 1999. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67: 2585.
76. 76. Kawakami K, Qureshi M H, Zhang T, Okamura H, Kurimoto M, Saito A. 1997. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J. Immunol. 159: 5528.
77. 77. Qureshi M H, Zhang T, Koguchi Y, Nakashima K, Okamura H, Kurimoto M, Kawakami K. 1999. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur: J. Immunol. 29: 643.
78. 78. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. 1998. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J. Immunol. 160: 6032.
79. 79. Fujioka N, Akazawa R, Ohashi K, Fuji M, Ikeda M, Kurimoto M. 1999. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol. 73: 2401.
80. 80. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S. 1999. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1 -dependent pathway. J. Immunol. 162: 7322.
81. 81. Meyer Zum Buschenfelde C, Cramer S, Trumpfheller C, Fleischer B, Frosch S. 1997. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production. Clin. Exp. Immunol. 110: 378.
82. 82. Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, Nakanuma Y, Tsutsui H, Okamura H, Nakanishi K, Tagawa Y, et al. 1999. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, 1L-12, and 1L-18 production. J. Immunol. 162: 1049.
83. 83. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K. 1997. IL-18 accounts for both TNF-alpha-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159: 3961.
84. 84. Sakao Y, Takeda K, Tsutsui H, Kaisho T, Nomura F, Okamura H, Nakanishi K, Akira S. 1999. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int. Immunol. 11: 471.
85. 85. Tartour E, Fridman W H. 1998. Cytokines and cancer. (Review) Intern. Rev. Immunol. 16: 683.
86. 86. Fridman W H, Tartour E. 1998. Macrophage-and lymphocyte-produced Th1 and Th2 cytokines in the tumour microenvironment. Res. Immunol. 149: 651.
87. 87. Boehm U, Klamp T, Groot M, Howard J C. 1997. Cellular responses to interferon-gamma. (Review) Annu. Rev. Immunol. 15:749.
88. 88. Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito M J, Oramas J. 1999. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11: 80.
89. 89. Tartour E, Gey A, Sastre-Garau X, Lombard Surin I, Mosseri V, Fridman W H. 1998. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J. Natl. Cancer Inst. 90: 287.
90. 90. Micallef M J, Yoshida K, Kawai S, Hanaya T, Kohno K, Arai S, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Kurimoto M. 1997. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol. Immunother. 43: 361.
91. 91. Yoshida Y, Tasaki K, Kimurai M, Takenaga K, Yamamoto H, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M. 1998. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells. Anticancer Res. 18: 333.
92. 92. Heuer J G, Tucker-McClung C, Hock R A. 1999. Neuroblastoma cells expressing mature IL-18, but not proIL-18, induce a strong and immediate antitumor immune response. J. Immunother. 22: 324.
93. 93. Osaki T, Peron J M, Cai Q, Okamura H, Robbins P D, Kurimoto M, Lotze M T, Tahara H. 1998. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma-and IL-12-independent antitumor effects. J. Immunol. 160: 1742.
94. 94. Coughlin C M, Salhany K E, Wysocka M, Aruga E, Kurzawa H, Chang A E, Hunter C A, Fox J C, Trinchieri G, Lee W M F. 1998. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101: 1441.
95. 95. Sarvetnick N. 1997. IFN-gamma, 1GIF, and IDDM. J. Clin. Invest. 99: 371.
96. 96. Rothe H, Hibino T, Itoh Y, Kolb H, Martin S. 1997. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. J. Autoimmun. 10: 251.
97. 97. Rothe H, Hausmann A, Casteel K, Okamura H, Kurimoto M, Burkart V, Mathieu C, Kolb H. 1999. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th 1-dependent destructive insulitis. J. fmmunol. 163: 1230.
98. 98. Tuohy V K, Yu M, Yin L, Kawczak J A, Johnson J M, Mathisen P M, Weinstock-Guttman B, Kinkel R P. 1998. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. (Review) Immunol. Rev. 164: 93.
99. 99. Jander S, Stoll G. 1998. Differential induction of interleukin-12, interleukin-18, and interleukin-1beta converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat. J. Neuroimmunol. 91: 93.
100. 100. Wildbaum G, Youssef S, GrabieN , Karin N. 1998. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161: 6368.
101. 101. Arend W P, Dayer J M. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. (Review) Arthritis. Rheum. 38: 151.
102. 102. Yamamura M, Kawashima M, Morita Y, Makino H, Tanimoto T, Kurimoto M. 1998. Increased production of Interleukin-18 in synovium from patients with rheumatoid arthritis. Arthritis. Rheum, (abstract) 40: s274.
103. 103. Desreumaux P, Brandt E, Gambiez L, Emilie D, Geboes K, Klein O, Ectors N, Cortot A, Capron M, Colomecl J F. 1997. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 113: 118.
104. 104. Reimund J M, Wittersheim C, Dumont S, Muller C D, Baumann R, Poindron P, Duclos B. 1996. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol. 16: 144.
105. 105. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. 1996. Increased interleukin-8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 38: 216.
106. 106. Mitsuyama K, Ide M, Nishiyama T, Tomiyasu N, Shirachi A, Saiki T, Tateishi H, Toyonaga A, Kurimoto M, Okamura H, et al. 1998. Role of interleukin-18 in a murine model of dextran sulfate sodium-induced colitis. Gastroenterology 114: G4258 (Abs).
107. 107. Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, Luzza F, Fusco A, Pallone F. 1999. Bioactive IL-18 expression is up-regulated in Crohn's Disease. J. Immunol. 163: 143.
108. 108. PizarroT T, Michie M H, Bentz M, Woraratanadharm J, Smith M F J, Foley E, Moskaluk C A, Bickston S J, Cominelli F. 1999. IL-18, a novel immunoregulatory cytokine, is upregulated in Crohn's disease: expression and localization in intestinal mucosai cells. J. Immunol. 162: 6829.
109. 109. Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, Kurimoto M. 1997. Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res. 289: 499.